We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$308M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$188M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$172M
4
PSA icon
Public Storage
PSA
+$47.9M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$46.9M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$53.7M
2
MCD icon
McDonald's
MCD
+$46.3M
3
SO icon
Southern Company
SO
+$33.8M
4
HEWJ icon
iShares Currency Hedged MSCI Japan ETF
HEWJ
+$26.3M
5
ETP
Energy Transfer Partners L.p.
ETP
+$24.9M

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
3026
CALL
Boston Scientific
BSX
$69.2B
$157K ﹤0.01%
20,000
– –
MTW icon
3027
Manitowoc
MTW
$512M
$157K ﹤0.01%
6,522
-250
-4% -$5.85K
KEM
3028
DELISTED
KEMET Corporation
KEM
$154K ﹤0.01%
12,038
-16,253
-57% -$206K
BLE
3029
DELISTED
BlackRock Municipal Income Trust II
BLE
$153K ﹤0.01%
+10,021
New +$152K
FUND
3030
Sprott Focus Trust
FUND
$301M
$153K ﹤0.01%
20,787
-322
-2% -$2.42K
NCA icon
3031
Nuveen California Municipal Value Fund
NCA
$301M
$153K ﹤0.01%
14,933
+100
+0.7% +$1.03K
TA
3032
DELISTED
TravelCenters of America LLC
TA
$153K ﹤0.01%
7,473
-4,934
-40% -$119K
SRV
3033
NXG Cushing Midstream Energy Fund
SRV
$216M
$152K ﹤0.01%
3,100
+550
+22% +$28.9K
INSY
3034
DELISTED
Insys Therapeutics, Inc.
INSY
$152K ﹤0.01%
+12,002
New +$142K
AXU
3035
DELISTED
Alexco Resource Corp
AXU
$151K ﹤0.01%
114,767
-1,705
-1% -$2.36K
GWRS icon
3036
Global Water Resources
GWRS
$211M
$150K ﹤0.01%
+15,200
New +$139K
TRIB
3037
Trinity Biotech
TRIB
$7.28M
$150K ﹤0.01%
167
-12
-7% -$10.2K
DWAT
3038
DELISTED
Arrow Investments Trust Arrow DWA Tactical ETF
DWAT
$149K ﹤0.01%
13,800
– –
WMC
3039
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$149K ﹤0.01%
1,445
– –
BAC.WS.A
3040
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$148K ﹤0.01%
12,312
+2,270
+23% +$25.2K
MFM
3041
Aberdeen Municipal Income Fund
MFM
$221M
$146K ﹤0.01%
20,567
+83
+0.4% +$591
MRK icon
3042
CALL
Merck
MRK
$317B
$146K ﹤0.01%
124,607
+14,043
+13% +$855K
TIME
3043
DELISTED
Time Inc.
TIME
$146K ﹤0.01%
10,151
-3,806
-27% -$56.8K
MNE
3044
DELISTED
Blackrock MUNI New York Intermediate Duration Fund, Inc.
MNE
$145K ﹤0.01%
10,345
– –
PZE
3045
DELISTED
Petrobras Argentina S A
PZE
$144K ﹤0.01%
+12,000
New +$146K
DAKT icon
3046
Daktronics
DAKT
$1.06B
$143K ﹤0.01%
14,830
-665
-4% -$6.27K
QHC
3047
DELISTED
Quorum Health Corporation
QHC
$143K ﹤0.01%
+34,528
New +$142K
UWN
3048
DELISTED
Nevada Gold & Casinos, Ltd.
UWN
$142K ﹤0.01%
63,300
– –
KGC icon
3049
Kinross Gold
KGC
$30.5B
$141K ﹤0.01%
34,650
+4,200
+14% +$16.7K
PNNT
3050
Pennant Park Investment Corp
PNNT
$227M
$140K ﹤0.01%
19,000
+5,000
+36% +$38.5K
120 121
122
123 124

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.